The outlook revision is based on Moody’s Investors Service’s expectation that CHS will maintain its stable operating performance and investment position.
The “Baa1” rating affirmation is representative of several factors, including CHS’ leading regional market position, low leverage and adequate liquidity. CHS also faces several challenges, including competition in its primary service area.
More articles on healthcare finance:
The most affordable and expensive states to give birth in
9 RCM takeaways from Becker’s 2nd Annual CIO/HIT + Revenue Cycle Conference
Fitch revises Wentworth-Douglass Hospital’s outlook to positive
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
